Our Strengths

At Cera Biologicals, our strengths lie in our unwavering commitment to quality, innovation, and regulatory excellence. These core attributes have enabled us to become a trusted name in sterile manufacturing, and they continue to drive our growth and success in the pharmaceutical industry.

State-of-the-Art Facility:

We operate a cutting-edge plant designed to meet the latest 2023-2024 sterile manufacturing standards, ensuring precise, efficient, and contamination-free production processes.

Regulatory Compliance:

Our manufacturing practices adhere to WHO-EU GMP and UK-MHRA standards, ensuring our products meet the strictest quality and safety regulations in both local and global markets.

Expertise in Sterile Manufacturing:

With a focus on dry powder and liquid injections, our team of highly trained professionals leverages industry-leading technology and processes to maintain product sterility and integrity.

Strong Partnerships:

Collaborating with major pharmaceutical companies such as Gland, Vasista, and BE Pharmaceuticals, we continually enhance our capabilities and expand our market reach.

Commitment to Innovation:

We continuously invest in the latest advancements in sterile manufacturing, ensuring that our processes and products remain at the forefront of the pharmaceutical industry.

Our strengths reflect our dedication to delivering the highest quality products, ensuring compliance with international standards, and maintaining a strong presence in the global pharmaceutical market.